Ignite Creation Date:
2024-05-06 @ 1:51 PM
Last Modification Date:
2024-10-26 @ 1:21 PM
Study NCT ID:
NCT04144517
Status:
COMPLETED
Last Update Posted:
2024-01-25
First Post:
2019-10-24
Brief Title:
A Study of ALKS 4230 Nemvaleukin Alfa With Pembrolizumab in Head and Neck Cancer
Sponsor:
Mural Oncology Inc
Organization:
Mural Oncology Inc
Organization Data
Organization:
Mural Oncology Inc
Class:
INDUSTRY
Study ID:
ION-01-ALKS 4230
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mural Oncology Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Immune Oncology Network | UNKNOWN |